BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

IntraPace, Inc. Announces Chuck Brynelsen As New CEO


10/19/2005 5:09:02 PM

MENLO PARK, Calif., July 27 /PRNewswire/ -- IntraPace, Inc. announced today that Chuck Brynelsen has joined the company as President and Chief Executive Officer after a 24-year career at medical device maker Medtronic, where he served in general management positions in a variety of business units.

Mir Imran, IntraPace Founder and Chairman of the board of directors stated, "We are delighted to have attracted a medical device executive with the breadth of experience Chuck brings to IntraPace. Under his leadership we expect IntraPace to serve a leading role in addressing the global obesity problem."

Immediately prior to joining IntraPace, Mr. Brynelsen was Vice President and General Manager of Medtronic's Cardiac Surgery Technologies business. Previous positions include Vice President and General Manager of Medtronic Perfusion Systems, Vice President and President Medtronic Asia Pacific, and Vice President Corporate Marketing.

Dr. Bruce Robertson, Managing Director at Toucan Capital and IntraPace Director stated, "During his long tenure at Medtronic, Chuck gained extensive experience in the application of electrical stimulation therapy for treating numerous cardiac and neurological diseases, experience that will be useful in the application of stimulation therapy to the problem of obesity." Mr. Brynelsen spent the early years of his career at Medtronic in the Cardiac Rhythm Management business participating in the introduction of dual chamber pacemakers, rate responsive pacemakers, implantable defibrillators, and bi-ventricular pacemakers.

Jeffrey Barnes, General Partner at Oxford Bioscience Partners and IntraPace Director stated, "Chuck's varied experience has provided him with a broad network of contacts throughout the medical device industry that can support him as he builds IntraPace." As Vice President of Corporate Marketing, Brynelsen led Medtronic's efforts on internal e-business applications and electronic communication with physicians and hospitals, Medtronic's traditional customers. He was instrumental in Medtronic's decision to become a founding member of the Global Healthcare Exchange and served as the Medtronic member of its Board of Directors. While in Japan, he worked closely with AdvaMed, the medical technology association representing manufacturers of medical devices, diagnostic products and medical information systems, as the Chairman of the Subcommittee on Medical Devices of the American Chamber of Commerce in Japan.

Mr. Brynelsen earned his BA degree from Bradley University and MBA degree from the Kellogg School of Management at Northwestern University.

Mr. Brynelsen stated, "I am pleased to join the outstanding team that Mir has assembled to build IntraPace. I am very impressed with the progress we are making and look forward to bringing this therapy to market."

IntraPace, Inc. is a medical device company developing endoscopically delivered implantable devices for the treatment of obesity. For further information please contact Mir Imran, mir@in-cube.com.

IntraPace, Inc.

CONTACT: Chuck Brynelsen, CEO of IntraPace, +1-650-289-5171



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES